761440-64-6 Usage
Description
1-(3-methoxy-4-nitrophenyl)piperidin-4-one is a chemical compound with the molecular formula C13H15N3O4. It is a piperidin-4-one derivative featuring a 3-methoxy-4-nitrophenyl group attached to the piperidine ring. 1-(3-methoxy-4-nitrophenyl)piperidin-4-one is recognized for its unique structure, which makes it a valuable component in medicinal chemistry and organic synthesis. Due to its potential as a building block in the synthesis of pharmaceuticals and other organic compounds, it has shown promise as an intermediate in the development of new drugs for various therapeutic applications. However, it is important to handle this compound with care and caution due to potential hazards associated with its use.
Uses
Used in Pharmaceutical Industry:
1-(3-methoxy-4-nitrophenyl)piperidin-4-one is used as a building block for the synthesis of pharmaceuticals, contributing to the development of new drugs for a range of therapeutic applications. Its unique structure allows it to be a key intermediate in the creation of various medicinal compounds.
Used in Organic Synthesis:
In the field of organic synthesis, 1-(3-methoxy-4-nitrophenyl)piperidin-4-one serves as a valuable component for creating a variety of organic compounds. Its versatility in chemical reactions makes it an essential part of many synthesis processes.
Check Digit Verification of cas no
The CAS Registry Mumber 761440-64-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,6,1,4,4 and 0 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 761440-64:
(8*7)+(7*6)+(6*1)+(5*4)+(4*4)+(3*0)+(2*6)+(1*4)=156
156 % 10 = 6
So 761440-64-6 is a valid CAS Registry Number.
761440-64-6Relevant articles and documents
Synthesis method of Brigatinib intermediate
-
Paragraph 0034-0038; 0044-0051, (2021/06/26)
The invention discloses a synthesis method of a Brigatinib intermediate. The Brigatinib intermediate is 2-methoxy-4-(4-(4-methyl piperazine-1-yl) piperidine-1-yl) aniline (I). The synthesis method comprises the following steps: taking 5-fluoro-2-nitroanis
Preparation method and crystal form of deuterated diphenyl amino pyrimidine compound
-
Paragraph 0340-0344, (2019/04/27)
The present invention discloses a preparation method and a crystal form of a compound shown in the formula (A) and also discloses a pharmaceutical composition comprising the crystal form of the compound shown in the formula (A) and a method for treating A
2,4-dibasic miazines compound
-
, (2017/08/29)
The invention belongs to the field of medical chemistry, relates to a 2,4-dibasic miazines compound and specifically relates to a compound shown as formula (I) or a pharmaceutically acceptable salt thereof, a drug compound thereof and an application thereof in treating EGFR or/and ALK mediated diseases.
